Patent · US Active

STAT3 inhibitor

US9562002B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Jia Zhou · Galveston, US
Haijun Chen · Shanghai, CN
Qiang Shen · Ottawa, CA

Key dates

Filing date	Jan 15, 2014
Grant date	Feb 7, 2017
Priority date	—
Expiry date	Jan 15, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are STAT3 inhibitors and methods of treating inflammation or a hyperproliferative disease such as, e.g., cancer. In some aspects, compounds may be used to treat breast cancer, a head/neck cancer, a lung cancer, a prostate cancer, or pancreatic cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.